N
Nordic Bioscience
Biotech & Life Sciences · Herlev, Denmark · Founded 1991
World-leading specialist in biomarkers, clinical development and speciality laboratory services MoreLess
Nordic Bioscience is a specialized company focused on biomarker development and clinical trials, particularly in the fields of rheumatology and fibrosis. Operating in the biotechnology and pharmaceutical sectors, the company leverages over 25 years of experience to offer customized assay development and research programs. Nordic Bioscience serves pharmaceutical companies, research institutions, and healthcare providers by providing high-quality biomarker analysis and clinical trial services. The company generates revenue through service contracts, research collaborations, and licensing agreements. Its business model is built on delivering precision medicine solutions using unique biomarker technologies, which help in the early detection and treatment of diseases. The company is privately owned, allowing for swift decision-making and adaptability to market needs.
Keywords: biomarkers, clinical trials, precision medicine, rheumatology, fibrosis, assay development, pharmaceutical, biotechnology, research programs, healthcare.
Talent graph
Nordic Bioscience's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Nordic Bioscience has talent and traffic
team presence
across markets
Market sentiment
What the market is saying about Nordic Bioscience
An AI-synthesized read of the highest-engagement posts about Nordic Bioscience on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nordic Bioscience on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.